JP2005514440A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005514440A5 JP2005514440A5 JP2003559494A JP2003559494A JP2005514440A5 JP 2005514440 A5 JP2005514440 A5 JP 2005514440A5 JP 2003559494 A JP2003559494 A JP 2003559494A JP 2003559494 A JP2003559494 A JP 2003559494A JP 2005514440 A5 JP2005514440 A5 JP 2005514440A5
- Authority
- JP
- Japan
- Prior art keywords
- aerosol composition
- group
- medical aerosol
- propellant
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 claims description 16
- 239000000443 aerosol Substances 0.000 claims description 15
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 8
- 239000003380 propellant Substances 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000003368 amide group Chemical group 0.000 claims description 2
- YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 claims 1
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 150000001412 amines Chemical group 0.000 claims 1
- -1 auxiliaries Substances 0.000 claims 1
- 239000012752 auxiliary agent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000006184 cosolvent Substances 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34262301P | 2001-12-21 | 2001-12-21 | |
| PCT/US2002/041251 WO2003059331A2 (en) | 2001-12-21 | 2002-12-20 | Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005514440A JP2005514440A (ja) | 2005-05-19 |
| JP2005514440A5 true JP2005514440A5 (US20040097461A1-20040520-C00002.png) | 2006-02-09 |
Family
ID=23342584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003559494A Withdrawn JP2005514440A (ja) | 2001-12-21 | 2002-12-20 | アミドおよび／またはエステルを含有する、賦形剤化合物を含む、医用エアロゾル組成物 |
Country Status (8)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1458354A1 (en) * | 2001-12-21 | 2004-09-22 | 3M Innovative Properties Company | Medicinal aerosol formulations comprising ion pair complexes |
| JP2005514440A (ja) | 2001-12-21 | 2005-05-19 | スリーエム イノベイティブ プロパティズ カンパニー | アミドおよび／またはエステルを含有する、賦形剤化合物を含む、医用エアロゾル組成物 |
| CA2470520A1 (en) * | 2001-12-21 | 2003-07-24 | 3M Innovative Properties Company | Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
| US20050123484A1 (en) * | 2003-10-02 | 2005-06-09 | Collegium Pharmaceutical, Inc. | Non-flammable topical anesthetic liquid aerosols |
| US20060188449A1 (en) * | 2003-10-03 | 2006-08-24 | Jane Hirsh | Topical aerosol foams |
| US20050255048A1 (en) * | 2004-05-15 | 2005-11-17 | Collegium Pharmaceutical, Inc. | Sprayable formulations for the treatment of acute inflammatory skin conditions |
| GB0614621D0 (en) | 2006-07-24 | 2006-08-30 | 3M Innovative Properties Co | Metered dose dispensers |
| GB0620700D0 (en) | 2006-10-19 | 2006-11-29 | 3M Innovative Properties Co | Metered dose valves and dispensers |
| US8652443B2 (en) * | 2008-02-14 | 2014-02-18 | Precision Dermatology, Inc. | Foamable microemulsion compositions for topical administration |
| GB201118188D0 (en) | 2011-10-21 | 2011-12-07 | 3M Innovative Properties Co | Manufacture of medicinal aerosol canisters |
| GB201210580D0 (en) | 2012-06-14 | 2012-08-01 | 3M Innovative Properties Co | Metered dose dispensing valve |
| GB201221063D0 (en) | 2012-11-23 | 2013-01-09 | 3M Innovative Properties Co | Metered dose dispensing valve |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225183A (en) | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| WO1994008599A1 (en) * | 1992-10-14 | 1994-04-28 | The Regents Of The University Of Colorado | Ion-pairing of drugs for improved efficacy and delivery |
| PL177078B1 (pl) | 1992-12-09 | 1999-09-30 | Boehringer Ingelheim Pharma | Preparaty roztworów aerozolowych |
| EP0689424B1 (en) | 1993-03-17 | 1998-10-14 | Minnesota Mining And Manufacturing Company | Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
| WO1994021228A1 (en) | 1993-03-17 | 1994-09-29 | Minnesota Mining And Manufacturing Company | Aerosol formulation containing a diol-diacid derived dispersing aid |
| US5492688A (en) | 1993-04-28 | 1996-02-20 | The Center For Innovative Technology | Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent |
| ATE233544T1 (de) | 1993-12-02 | 2003-03-15 | Abbott Lab | Aerosole als darreichungsform mit cfc-freiem treibmittel |
| US5508023A (en) | 1994-04-11 | 1996-04-16 | The Center For Innovative Technology | Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant |
| US6524557B1 (en) | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| US5650386A (en) | 1995-03-31 | 1997-07-22 | Emisphere Technologies, Inc. | Compositions for oral delivery of active agents |
| US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
| US6218353B1 (en) | 1997-08-27 | 2001-04-17 | Micell Technologies, Inc. | Solid particulate propellant systems and aerosol containers employing the same |
| US6136294C1 (en) | 1998-09-22 | 2002-09-24 | Aeropharm Technology Inc | Amino acid stabilized medical aerosol formulation |
| CA2340225A1 (en) | 1998-10-27 | 2000-05-04 | Wesley Wehsin Han | Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| US6258857B1 (en) * | 1999-02-04 | 2001-07-10 | Kyowa Industrial Co., Ltd. | Internal liquid composition contained as internal liquid in a releasing container and releasing container product |
| US20040142475A1 (en) * | 2000-06-02 | 2004-07-22 | Barman Shikha P. | Delivery systems for bioactive agents |
| EP1458354A1 (en) * | 2001-12-21 | 2004-09-22 | 3M Innovative Properties Company | Medicinal aerosol formulations comprising ion pair complexes |
| JP2005514440A (ja) | 2001-12-21 | 2005-05-19 | スリーエム イノベイティブ プロパティズ カンパニー | アミドおよび／またはエステルを含有する、賦形剤化合物を含む、医用エアロゾル組成物 |
| CA2470520A1 (en) * | 2001-12-21 | 2003-07-24 | 3M Innovative Properties Company | Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
-
2002
- 2002-12-20 JP JP2003559494A patent/JP2005514440A/ja not_active Withdrawn
- 2002-12-20 AU AU2002364594A patent/AU2002364594A1/en not_active Abandoned
- 2002-12-20 US US10/327,198 patent/US7186402B2/en not_active Expired - Fee Related
- 2002-12-20 EP EP02799975A patent/EP1455764B1/en not_active Expired - Lifetime
- 2002-12-20 CA CA002470498A patent/CA2470498A1/en not_active Abandoned
- 2002-12-20 AT AT02799975T patent/ATE406152T1/de not_active IP Right Cessation
- 2002-12-20 WO PCT/US2002/041251 patent/WO2003059331A2/en active Application Filing
- 2002-12-20 DE DE60228615T patent/DE60228615D1/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2403258C2 (ru) | Тиазолилдигидроиндазолы | |
| ES2271642T3 (es) | Derivados de tiazol como inhibidores de la fosfodieterasa iv. | |
| JP2005514440A5 (US20040097461A1-20040520-C00002.png) | ||
| JP2001526218A5 (US20040097461A1-20040520-C00002.png) | ||
| EP0521827B1 (de) | Pharmakologisch wirksame Hydrazinderivate und Verfahren zu deren Herstellung | |
| RU2002123350A (ru) | Дипептиднитрильные ингибиторы катепсина К | |
| DK1487829T3 (da) | Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte | |
| JP2009519345A5 (US20040097461A1-20040520-C00002.png) | ||
| EP0832099A1 (en) | Reversible cysteine protease inhibitors | |
| DK1140745T3 (da) | Colchinolderivater som vaskulært skadelige midler | |
| CY1110593T1 (el) | Η χρηση φαρμακευτικης συνθεσης που περιεχει παραγωγο παρα - αμινοφαινυλοξικου οξεος για τη θεραπεια των φλεγμονωδων καταστασεων του γαστρεντερικου σωληνα | |
| HUP0302980A2 (hu) | Lipofil és ionizálható molekularészeket tartalmazó protein junkinázgátló hatású szulfonamid-származékok és ezeket tartalmazó gyógyszerkészítmények | |
| JP2006501181A5 (US20040097461A1-20040520-C00002.png) | ||
| NO20060981L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
| MY148937A (en) | Medicaments with hm74a receptor activity | |
| PL409123A1 (pl) | Związki, ich zastosowanie i kompozycje do leczenia wirusowego zapalenia wątroby typu C | |
| JP2005502621A5 (US20040097461A1-20040520-C00002.png) | ||
| JP2006515585A5 (US20040097461A1-20040520-C00002.png) | ||
| CA2589744A1 (en) | Pyrrolinidium derivatives as m3 muscarinic receptors | |
| ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
| NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
| RU2003134629A (ru) | Соединения цефема | |
| AR065297A1 (es) | Formulaciones biodisponibles de compuestos heterociclicos | |
| JP2006502086A5 (US20040097461A1-20040520-C00002.png) | ||
| ES2564144T3 (es) | Derivados de 6-[2-(fosfonometoxi)alcoxi] pirimidina que tienen actividad antivírica |
